by Gothami Samaraweera - Research Assistant | SEO Content Writer | Health and Wellness | Mar 21, 2026 | Zepbound
Tirzepatide is one of the newest medications in the GLP-1 weight loss landscape. The U.S. Food and Drug Administration (FDA) approved it in November 2023 for adults with obesity or those who are overweight with weight-related health conditions. Zepbound became the...
by Gothami Samaraweera - Research Assistant | SEO Content Writer | Health and Wellness | Mar 20, 2026 | Ozempic
Ozempic (semaglutide) has rapidly become one of the most in demand prescription medications today. Prescriptions for Ozempic have increased by 300% over the past few years with more than 15 million people now using it or a similar GLP-1 medication. The Food and Drug...
by Gothami Samaraweera - Research Assistant | SEO Content Writer | Health and Wellness | Mar 19, 2026 | Ozempic
Ozempic is one of the most widely prescribed medications in the United States with semaglutide as the active ingredient. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking a natural hormone that helps regulate blood sugar levels,...
by Gothami Samaraweera - Research Assistant | SEO Content Writer | Health and Wellness | Mar 19, 2026 | Wegovy
Wegovy is a widely used weight-loss medication in the United States with semaglutide as the active ingredient. It is approved by the U.S. Food and Drug Administration (FDA) for long term weight management in adults with obesity or those who are overweight with related...
by Gothami Samaraweera - Research Assistant | SEO Content Writer | Health and Wellness | Mar 19, 2026 | Tirzepatide
Do you have any idea about the new weight loss medications trending across social media? GLP-1(Glucagon-like Peptide-1) and GIP(Glucose-dependent Insulinotropic Polypeptide) medications such as Mounjaro (tirzepatide), Zepbound (tirzepatide) and Ozempic (semaglutide)...